John Maraganore, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 96,600 shares at $102.51 ($10.2M) on 2018-07-25, disclosed to the SEC on 2018-07-27.
Open-market sale of $10.2M ALNY by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $102.51 | 2,000 | $205K | 2.0% |
| 2 | $103.69 | 3,847 | $399K | 3.9% |
| 3 | $103.69 | 3,847 | $399K | 3.9% |
| 4 | $104.83 | 7,758 | $813K | 8.0% |
| 5 | $104.83 | 7,758 | $813K | 8.0% |
| 6 | $105.83 | 34,995 |
| $3.7M |
| 36.4% |
| 7 | $105.83 | 34,995 | $3.7M | 36.4% |
| 8 | $106.25 | 1,400 | $149K | 1.5% |
| Total | $105.44 avg | 96,600 | $10.2M | 100% |
| Filing → |
| ALNY | SELL | 2021-05-17 | $8.9M | — | Filing → |
| ALNY | SELL | 2021-02-26 | $9.4M | — | Filing → |
| ALNY | SELL | 2020-11-20 | $8.6M | — | Filing → |